Global Biosimilar Monoclonal Antibodies Market Report 2019 - Industry Analysis, Size, production, prospects, consumption and cost structure Analysis and forecast to 2025

 Buy Now

   Published Date : Jan-2019   |    Format : PDF   |    Pages : 109
The global Biosimilar Monoclonal Antibodies market is valued at  million US$ in 2018 is expected to reach  million US$ by the end of 2025, growing at a CAGR of  during 2019-2025.
This report focuses on Biosimilar Monoclonal Antibodies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biosimilar Monoclonal Antibodies market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    ProMab Biotechnologies
    Allergan plc
    Abbott
    BioXpress Therapeutics
    Bayer
    Bio Farma
    Merck
    Therapeutics
    Biocon
    Boehringer Ingelheim
    Celltrion Inc.
    Coherus BioSciences Inc.
    Zydus-Cadila
    Genor BioPharma
    Intas Pharmaceuticals
    Novartis
    Pfizer
    Reliance Life Sciences

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Infliximab
    Rituximab
    Abciximab
    Trastuzumab
    Adalimumab
    Bevacizumab

Segment by Application
    Oncology
    Chronic and Autoimmune Diseases
    Growth Hormone Deficiency
    Infectious Diseases
    Others

Executive Summary
1 Biosimilar Monoclonal Antibodies Market Overview
    1.1 Product Overview and Scope of Biosimilar Monoclonal Antibodies
    1.2 Biosimilar Monoclonal Antibodies Segment by Type
        1.2.1 Global Biosimilar Monoclonal Antibodies Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Infliximab
        1.2.3 Rituximab
        1.2.4 Abciximab
        1.2.5 Trastuzumab
        1.2.6 Adalimumab
        1.2.7 Bevacizumab
    1.3 Biosimilar Monoclonal Antibodies Segment by Application
        1.3.1 Biosimilar Monoclonal Antibodies Consumption Comparison by Application (2014-2025)
        1.3.2 Oncology
        1.3.3 Chronic and Autoimmune Diseases
        1.3.4 Growth Hormone Deficiency
        1.3.5 Infectious Diseases
        1.3.6 Others
    1.3 Global Biosimilar Monoclonal Antibodies Market by Region
        1.3.1 Global Biosimilar Monoclonal Antibodies Market Size Region
        1.3.2 North America Status and Prospect (2014-2025)
        1.3.3 Europe Status and Prospect (2014-2025)
        1.3.4 China Status and Prospect (2014-2025)
        1.3.5 Japan Status and Prospect (2014-2025)
        1.3.6 Southeast Asia Status and Prospect (2014-2025)
        1.3.7 India Status and Prospect (2014-2025)
    1.4 Global Biosimilar Monoclonal Antibodies Market Size
        1.4.1 Global Biosimilar Monoclonal Antibodies Revenue (2014-2025)
        1.4.2 Global Biosimilar Monoclonal Antibodies Production (2014-2025)

2 Global Biosimilar Monoclonal Antibodies Market Competition by Manufacturers
    2.1 Global Biosimilar Monoclonal Antibodies Production Market Share by Manufacturers (2014-2019)
    2.2 Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2014-2019)
    2.3 Global Biosimilar Monoclonal Antibodies Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Biosimilar Monoclonal Antibodies Production Sites, Area Served, Product Types
    2.5 Biosimilar Monoclonal Antibodies Market Competitive Situation and Trends
        2.5.1 Biosimilar Monoclonal Antibodies Market Concentration Rate
        2.5.2 Biosimilar Monoclonal Antibodies Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Biosimilar Monoclonal Antibodies Production Market Share by Regions
    3.1 Global Biosimilar Monoclonal Antibodies Production Market Share by Regions
    3.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions (2014-2019)
    3.3 Global Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
    3.4 North America Biosimilar Monoclonal Antibodies Production
        3.4.1 North America Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
        3.4.2 North America Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
    3.5 Europe Biosimilar Monoclonal Antibodies Production
        3.5.1 Europe Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
        3.5.2 Europe Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
    3.6 China Biosimilar Monoclonal Antibodies Production (2014-2019)
        3.6.1 China Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
        3.6.2 China Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
    3.7 Japan Biosimilar Monoclonal Antibodies Production (2014-2019)
        3.7.1 Japan Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
        3.7.2 Japan Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Biosimilar Monoclonal Antibodies Consumption by Regions
    4.1 Global Biosimilar Monoclonal Antibodies Consumption by Regions
    4.2 North America Biosimilar Monoclonal Antibodies Consumption (2014-2019)
    4.3 Europe Biosimilar Monoclonal Antibodies Consumption (2014-2019)
    4.4 China Biosimilar Monoclonal Antibodies Consumption (2014-2019)
    4.5 Japan Biosimilar Monoclonal Antibodies Consumption (2014-2019)

5 Global Biosimilar Monoclonal Antibodies Production, Revenue, Price Trend by Type
    5.1 Global Biosimilar Monoclonal Antibodies Production Market Share by Type (2014-2019)
    5.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2014-2019)
    5.3 Global Biosimilar Monoclonal Antibodies Price by Type (2014-2019)
    5.4 Global Biosimilar Monoclonal Antibodies Production Growth by Type (2014-2019)

6 Global Biosimilar Monoclonal Antibodies Market Analysis by Applications
    6.1 Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2014-2019)
    6.2 Global Biosimilar Monoclonal Antibodies Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Biosimilar Monoclonal Antibodies Business
    7.1 ProMab Biotechnologies
        7.1.1 ProMab Biotechnologies Biosimilar Monoclonal Antibodies Production Sites and Area Served
        7.1.2 Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
        7.1.3 ProMab Biotechnologies Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
        7.1.4 Main Business and Markets Served
    7.2 Allergan plc
        7.2.1 Allergan plc Biosimilar Monoclonal Antibodies Production Sites and Area Served
        7.2.2 Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
        7.2.3 Allergan plc Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
        7.2.4 Main Business and Markets Served
    7.3 Abbott
        7.3.1 Abbott Biosimilar Monoclonal Antibodies Production Sites and Area Served
        7.3.2 Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
        7.3.3 Abbott Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
        7.3.4 Main Business and Markets Served
    7.4 BioXpress Therapeutics
        7.4.1 BioXpress Therapeutics Biosimilar Monoclonal Antibodies Production Sites and Area Served
        7.4.2 Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
        7.4.3 BioXpress Therapeutics Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
        7.4.4 Main Business and Markets Served
    7.5 Bayer
        7.5.1 Bayer Biosimilar Monoclonal Antibodies Production Sites and Area Served
        7.5.2 Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
        7.5.3 Bayer Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
        7.5.4 Main Business and Markets Served
    7.6 Bio Farma
        7.6.1 Bio Farma Biosimilar Monoclonal Antibodies Production Sites and Area Served
        7.6.2 Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
        7.6.3 Bio Farma Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
        7.6.4 Main Business and Markets Served
    7.7 Merck
        7.7.1 Merck Biosimilar Monoclonal Antibodies Production Sites and Area Served
        7.7.2 Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
        7.7.3 Merck Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
        7.7.4 Main Business and Markets Served
    7.8 Therapeutics
        7.8.1 Therapeutics Biosimilar Monoclonal Antibodies Production Sites and Area Served
        7.8.2 Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
        7.8.3 Therapeutics Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
        7.8.4 Main Business and Markets Served
    7.9 Biocon
        7.9.1 Biocon Biosimilar Monoclonal Antibodies Production Sites and Area Served
        7.9.2 Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
        7.9.3 Biocon Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
        7.9.4 Main Business and Markets Served
    7.10 Boehringer Ingelheim
        7.10.1 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Production Sites and Area Served
        7.10.2 Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
        7.10.3 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
        7.10.4 Main Business and Markets Served
    7.11 Celltrion Inc.
    7.12 Coherus BioSciences Inc.
    7.13 Zydus-Cadila
    7.14 Genor BioPharma
    7.15 Intas Pharmaceuticals
    7.16 Novartis
    7.17 Pfizer
    7.18 Reliance Life Sciences

8 Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis
    8.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
    8.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
    8.4 Biosimilar Monoclonal Antibodies Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
    9.2 Biosimilar Monoclonal Antibodies Distributors List
    9.3 Biosimilar Monoclonal Antibodies Customers

10 Market Dynamics
    10.1 Market Trends
    10.2 Opportunities
    10.3 Market Drivers
    10.4 Challenges
    10.5 Influence Factors

11 Global Biosimilar Monoclonal Antibodies Market Forecast
    11.1 Global Biosimilar Monoclonal Antibodies Production, Revenue Forecast
        11.1.1 Global Biosimilar Monoclonal Antibodies Production Growth Rate Forecast (2019-2025)
        11.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2019-2025)
        11.1.3 Global Biosimilar Monoclonal Antibodies Price and Trend Forecast (2019-2025)
    11.2 Global Biosimilar Monoclonal Antibodies Production Forecast by Regions (2019-2025)
        11.2.1 North America Biosimilar Monoclonal Antibodies Production, Revenue Forecast (2019-2025)
        11.2.2 Europe Biosimilar Monoclonal Antibodies Production, Revenue Forecast (2019-2025)
        11.2.3 China Biosimilar Monoclonal Antibodies Production, Revenue Forecast (2019-2025)
        11.2.4 Japan Biosimilar Monoclonal Antibodies Production, Revenue Forecast (2019-2025)
    11.3 Global Biosimilar Monoclonal Antibodies Consumption Forecast by Regions (2019-2025)
        11.3.1 North America Biosimilar Monoclonal Antibodies Consumption Forecast (2019-2025)
        11.3.2 Europe Biosimilar Monoclonal Antibodies Consumption Forecast (2019-2025)
        11.3.3 China Biosimilar Monoclonal Antibodies Consumption Forecast (2019-2025)
        11.3.4 Japan Biosimilar Monoclonal Antibodies Consumption Forecast (2019-2025)
    11.4 Global Biosimilar Monoclonal Antibodies Production, Revenue and Price Forecast by Type (2019-2025)
    11.5 Global Biosimilar Monoclonal Antibodies Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Author List
    13.4 Disclaimer



List of Tables and Figures

    Figure Picture of Biosimilar Monoclonal Antibodies
    Table Global Biosimilar Monoclonal Antibodies Production (K Units) Growth Rate Comparison by Types (2014-2025)
    Figure Global Biosimilar Monoclonal Antibodies Production Market Share by Types in 2018
    Figure  Infliximab Product Picture
    Table Infliximab Major Manufacturers
    Figure Rituximab Product Picture
    Table Rituximab Major Manufacturers
    Figure Abciximab Product Picture
    Table Abciximab Major Manufacturers
    Figure Trastuzumab Product Picture
    Table Trastuzumab Major Manufacturers
    Figure Adalimumab Product Picture
    Table Adalimumab Major Manufacturers
    Figure Bevacizumab Product Picture
    Table Bevacizumab Major Manufacturers
    Table Global Biosimilar Monoclonal Antibodies Consumption (K Units) Comparison by Applications (2014-2025)
    Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Applications in 2018
    Figure Oncology
    Figure Chronic and Autoimmune Diseases
    Figure Growth Hormone Deficiency
    Figure Infectious Diseases
    Figure Others
    Table Biosimilar Monoclonal Antibodies Market Size (Million US$) Comparison by Regions (2014-2025)
    Figure North America Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2014-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2014-2025)
    Figure China Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2014-2025)
    Figure Japan Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2014-2025)
    Figure Global Biosimilar Monoclonal Antibodies Revenue (Million USD) (2014-2025)
    Figure Global Biosimilar Monoclonal Antibodies Production (K Units) (2014-2025)
    Table Global Biosimilar Monoclonal Antibodies Production (K Units) of Key Manufacturers (2014-2019)
    Table Global Biosimilar Monoclonal Antibodies Production Share by Manufacturers (2014-2019)
    Figure Biosimilar Monoclonal Antibodies Production Share by Manufacturers in 2018
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) by Manufacturers (2014-2019)
    Table Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers in 2018
    Table Global Market Biosimilar Monoclonal Antibodies Average Price (USD/Unit) of Key Manufacturers (2014-2019)
    Figure Global Market Biosimilar Monoclonal Antibodies Average Price (USD/Unit) of Key Manufacturers in 2018
    Table Manufacturers Biosimilar Monoclonal Antibodies Production Sites and Area Served
    Table Manufacturers Biosimilar Monoclonal Antibodies Product Types
    Figure Biosimilar Monoclonal Antibodies Market Share of Top 5 Manufacturers
    Figure Biosimilar Monoclonal Antibodies Market Share of Top 10 Manufacturers
    Table Global Biosimilar Monoclonal Antibodies Production (K Units) by Region (2014-2019)
    Table Global Biosimilar Monoclonal Antibodies Production Market Share by Region (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Production Market Share by Region (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Production Market Share by Region in 2018
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) by Region (2014-2019)
    Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region in 2018
    Figure Global Biosimilar Monoclonal Antibodies Production (K Units) Growth Rate (2014-2019)
    Table Global Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Figure North America Biosimilar Monoclonal Antibodies Production (K Units) Growth Rate (2014-2019)
    Table North America Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Figure Europe Biosimilar Monoclonal Antibodies Production (K Units) Growth Rate (2014-2019)
    Table Europe Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Figure China Biosimilar Monoclonal Antibodies Production (K Units) Growth Rate (2014-2019)
    Table China Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Figure Japan Biosimilar Monoclonal Antibodies Production (K Units) Growth Rate (2014-2019)
    Table Japan Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Global Biosimilar Monoclonal Antibodies Consumption (K Units) Market by Region (2014-2019)
    Table Global Biosimilar Monoclonal Antibodies Consumption Market Share by Region (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Region (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Region in 2018
    Figure North America Biosimilar Monoclonal Antibodies Consumption Growth Rate (2014-2019) (K Units)
    Figure Europe Biosimilar Monoclonal Antibodies Consumption Growth Rate (2014-2019) (K Units)
    Figure China Biosimilar Monoclonal Antibodies Consumption Growth Rate (2014-2019) (K Units)
    Figure Japan Biosimilar Monoclonal Antibodies Consumption Growth Rate (2014-2019) (K Units)
    Table Global Biosimilar Monoclonal Antibodies Production (K Units) by Type (2014-2019)
    Table Global Biosimilar Monoclonal Antibodies Production Share by Type (2014-2019)
    Figure Production Market Share of Biosimilar Monoclonal Antibodies by Type (2014-2019)
    Figure Production Market Share of Biosimilar Monoclonal Antibodies by Type in 2018
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) by Type (2014-2019)
    Table Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2014-2019)
    Figure Revenue Share of Biosimilar Monoclonal Antibodies by Type (2014-2019)
    Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Type in 2018
    Table Global Biosimilar Monoclonal Antibodies Price (USD/Unit) by Type (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Production Growth by Type (2014-2019) (K Units)
    Table Global Biosimilar Monoclonal Antibodies Consumption (K Units) by Application (2014-2019)
    Table Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Applications (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2018
    Table Global Biosimilar Monoclonal Antibodies Consumption Growth Rate by Application (2014-2019)
    Figure Global Biosimilar Monoclonal Antibodies Consumption Growth Rate by Application (2014-2019)
    Table ProMab Biotechnologies Biosimilar Monoclonal Antibodies Production Sites and Area Served
    Table ProMab Biotechnologies Product Introduction, Application and Specification
    Table ProMab Biotechnologies Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Figure ProMab Biotechnologies Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
    Figure ProMab Biotechnologies Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
    Figure ProMab Biotechnologies Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
    Table ProMab Biotechnologies Main Business and Markets Served
    Table Allergan plc Biosimilar Monoclonal Antibodies Production Sites and Area Served
    Table Allergan plc Product Introduction, Application and Specification
    Table Allergan plc Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Figure Allergan plc Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
    Figure Allergan plc Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
    Figure Allergan plc Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
    Table Allergan plc Main Business and Markets Served
    Table Abbott Biosimilar Monoclonal Antibodies Production Sites and Area Served
    Table Abbott Product Introduction, Application and Specification
    Table Abbott Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Figure Abbott Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
    Figure Abbott Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
    Figure Abbott Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
    Table Abbott Main Business and Markets Served
    Table BioXpress Therapeutics Biosimilar Monoclonal Antibodies Production Sites and Area Served
    Table BioXpress Therapeutics Product Introduction, Application and Specification
    Table BioXpress Therapeutics Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Figure BioXpress Therapeutics Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
    Figure BioXpress Therapeutics Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
    Figure BioXpress Therapeutics Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
    Table BioXpress Therapeutics Main Business and Markets Served
    Table Bayer Biosimilar Monoclonal Antibodies Production Sites and Area Served
    Table Bayer Product Introduction, Application and Specification
    Table Bayer Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Figure Bayer Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
    Figure Bayer Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
    Figure Bayer Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
    Table Bayer Main Business and Markets Served
    Table Bio Farma Biosimilar Monoclonal Antibodies Production Sites and Area Served
    Table Bio Farma Product Introduction, Application and Specification
    Table Bio Farma Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Figure Bio Farma Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
    Figure Bio Farma Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
    Figure Bio Farma Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
    Table Bio Farma Main Business and Markets Served
    Table Merck Biosimilar Monoclonal Antibodies Production Sites and Area Served
    Table Merck Product Introduction, Application and Specification
    Table Merck Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Figure Merck Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
    Figure Merck Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
    Figure Merck Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
    Table Merck Main Business and Markets Served
    Table Therapeutics Biosimilar Monoclonal Antibodies Production Sites and Area Served
    Table Therapeutics Product Introduction, Application and Specification
    Table Therapeutics Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Figure Therapeutics Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
    Figure Therapeutics Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
    Figure Therapeutics Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
    Table Therapeutics Main Business and Markets Served
    Table Biocon Biosimilar Monoclonal Antibodies Production Sites and Area Served
    Table Biocon Product Introduction, Application and Specification
    Table Biocon Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Figure Biocon Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
    Figure Biocon Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
    Figure Biocon Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
    Table Biocon Main Business and Markets Served
    Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Production Sites and Area Served
    Table Boehringer Ingelheim Product Introduction, Application and Specification
    Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Figure Boehringer Ingelheim Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
    Figure Boehringer Ingelheim Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
    Figure Boehringer Ingelheim Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
    Table Boehringer Ingelheim Main Business and Markets Served
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
    Figure Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
    Figure Biosimilar Monoclonal Antibodies Industrial Chain Analysis
    Table Biosimilar Monoclonal Antibodies Distributors List
    Table Biosimilar Monoclonal Antibodies Customers List
    Table Market Key Trends
    Table Key Opportunities
    Table Market Key Drivers
    Table Key Challenges
    Table Key Influence Factors
    Figure Global Biosimilar Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2019-2025)
    Figure Global Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2019-2025)
    Figure Global Biosimilar Monoclonal Antibodies Price and Trend Forecast (2019-2025)
    Table Global Biosimilar Monoclonal Antibodies Production (K Units) Forecast by Region (2019-2025)
    Figure Global Biosimilar Monoclonal Antibodies Production Market Share Forecast by Region (2019-2025)
    Figure North America Biosimilar Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2019-2025)
    Figure North America Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2019-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2019-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2019-2025)
    Figure China Biosimilar Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2019-2025)
    Figure China Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2019-2025)
    Figure Japan Biosimilar Monoclonal Antibodies Production (K Units) and Growth Rate Forecast (2019-2025)
    Figure Japan Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2019-2025)
    Table Global Biosimilar Monoclonal Antibodies Consumption (K Units) Forecast by Regions (2019-2025)
    Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share Forecast by Regions (2019-2025)
    Figure North America Biosimilar Monoclonal Antibodies Consumption (K Units) Growth Rate Forecast (2019-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Consumption (K Units) Growth Rate Forecast (2019-2025)
    Figure China Biosimilar Monoclonal Antibodies Consumption (K Units) Growth Rate Forecast (2019-2025)
    Figure Japan Biosimilar Monoclonal Antibodies Consumption (K Units) Growth Rate Forecast (2019-2025)
    Table Global Biosimilar Monoclonal Antibodies Production (K Units) Forecast by Type (2019-2025)
    Figure Global Biosimilar Monoclonal Antibodies Production (K Units) Forecast by Type (2019-2025)
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million USD) Forecast by Type (2019-2025)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Type (2019-2025)
    Table Global Biosimilar Monoclonal Antibodies Price (USD/Unit) Forecast by Type (2019-2025)
    Table Global Biosimilar Monoclonal Antibodies Consumption (K Units) Forecast by Application (2019-2025)
    Figure Global Biosimilar Monoclonal Antibodies Consumption Forecast by Application (2019-2025)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Chemicals & Materials

Industrial Alliance To Help Waste Management Market To Rise

An alliance of 28 large companies has launched a global organization to find solutions to remove plastic waste from the environment. The Alliance for the Disposal of Plastic Waste (AEPW), which collaborates with the World Business Council for Sustainable Development (WBCSD), brings together chemical and plastic companies as well as consumer goods companies.

25-Feb-2019 | Electrical & Electronic Device

Insights Into Fish’s Swimming Adds Sensory Feedback Feature To Global Robotics Market

The fish have a random movement with excellent sensory feedback so as to help them navigate the world. According to the Johns Hopkins University researchers, the inclusion of this movement in understanding the active sensing behaviors of animals can actually help advance the robotic platform in terms of medical, industrial, defense, and commercial sectors. The sensors can help improve the inter ...

13-Feb-2019 | Technology

Battle Between Apple And Qualcomm Likely To Impact The Growth Of The Smartphone Market

The smartphone market has observed a tremendous transformation owing to advancement in technology, better services, the advent of 4G & 5G networks, and so on. Recently, Qualcomm Inc had filed a patent lawsuit against Apple Inc that imposed a veto on sales of few iPhone devices in Germany. This, certainly, was expected to pose a negative impact on the growth of the smartphone market in that ...

13-Feb-2019 | Food & Beverage

Belizean Turmeric Gets Place in Global Turmeric Market

A novel product manufactured from Belizean-grown turmeric has started to hit the shelves of grocery stores in Belize as well as in Canada. The latest product is supposed to catch the turmeric market in the rest of the Caribbean as well. This budge is supposed to offer novel opportunities to farmers as well as agro-processors in the Toledo district. Till date, more than 350 turmeric cultivators ...

05-Feb-2019 | Automobile

Automotive Mobility Market Growth Has A Handle On New AEye Product Sale

The automotive mobility market will be skyrocketing by this year as AEye, which is one of the world’s best artificial perception systems and the maker of iDAR has recently declared that it will be launching the AE110. The new technology has been built on the highly wide-ranging solid-state LiDAR patent portfolio. The AE110 is the only one possessing the firm's solitary software-linked ...